Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM 100

2,775.00p
   
  • Change Today:
      50.00p
  • 52 Week High: 4,500.00
  • 52 Week Low: 2,350.00
  • Currency: UK Pounds
  • Shares Issued: 5.22m
  • Volume: 8,653
  • Market Cap: £144.99m

Latest Deals

Traded Action Notifier PriceAmountValue
28-Apr-25 Buy Bruce Hiscock 2,632.00p 31 £815.92
23-Dec-24 Buy Bruce Hiscock 273.00p 61 £166.53
22-Nov-24 Buy Bruce Hiscock 3,822.00p 24 £917.28
30-Oct-24 Buy Bruce Hiscock 3,330.00p 300 £9,990.00

Largest Deals (365 days)

Traded Action Notifier PriceAmountValue
30-Oct-24 Buy Bruce Hiscock 3,330.00p 300 £9,990.00
22-Nov-24 Buy Bruce Hiscock 3,822.00p 24 £917.28
28-Apr-25 Buy Bruce Hiscock 2,632.00p 31 £815.92
23-Dec-24 Buy Bruce Hiscock 273.00p 61 £166.53

Director Shareholdings

Notifier Holding Value*
Peter John Harrison 297,088 £8,244,192
Ian James Nicholson 13,000 £360,750
Bruce Hiscock 1,236 £34,299

Major Shareholders

Notifier** Holding Value*
Rathbones Investment Management Ltd 5,219,656 £144,845,454
Castlefield Fund Partners Limited 985,000 £27,333,750
SANFORD DELAND ASSET MANAGEMENT LTD 885,000 £24,558,750
Gresham House Asset Management Limited 627,782 £17,420,950
SANFORD DELAND ASSET MANAGEMENT LTD 619,500 £17,191,125
Miton Group plc 508,135 £14,100,746
The Diverse Income Trust plc 302,300 £8,388,825
Schroders plc 284,795 £7,903,061
Wasatch Advisors, Inc. 265,000 £7,353,750
Canaccord Genuity Group Inc 259,940 £7,213,335
Adrian Williams 253,372 £7,031,073

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Bioventix Market Data

Currency UK Pounds
Share Price 2,775.00p
Change Today 50.00p
% Change 1.83 %
52 Week High 4,500.00
52 Week Low 2,350.00
Volume 8,653
Shares Issued 5.22m
Market Cap £144.99m

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
17.77% below the market average17.77% below the market average17.77% below the market average17.77% below the market average17.77% below the market average
82.61% above the sector average82.61% above the sector average82.61% above the sector average82.61% above the sector average82.61% above the sector average
Price Trend
65.33% below the market average65.33% below the market average65.33% below the market average65.33% below the market average65.33% below the market average
21.74% below the sector average21.74% below the sector average21.74% below the sector average21.74% below the sector average21.74% below the sector average
Income
44.75% above the market average44.75% above the market average44.75% above the market average44.75% above the market average44.75% above the market average
42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average
Growth
9.36% below the market average9.36% below the market average9.36% below the market average9.36% below the market average9.36% below the market average
31.25% below the sector average31.25% below the sector average31.25% below the sector average31.25% below the sector average31.25% below the sector average

Bioventix Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 10-Apr-25 07-Nov-24
Paid 25-Apr-25 21-Nov-24
Amount 70.00p 87.00p

Trades for 11-Jul-2025

Time Volume / Share Price
16:29 100 @ 2,774.00p
15:05 1,210 @ 2,752.50p
15:05 1,210 @ 2,750.00p
14:23 5 @ 2,750.00p
13:04 1,000 @ 2,751.00p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
CFO Bruce Hiscock

Top of Page